"The decision is incomprehensible"
The European Medicines Agency (EMA) has recommended the refusal of the marketing authorization for the novel Alzheimer’s drug “Lecanemab” (brand name:…
SMA appears to be preceded by abnormalities in embryonic development that have not yet been recognized and could hold approaches for therapy.
SMA appears to be preceded by abnormalities in embryonic…
European Medicines Agency recommends refusal of marketing authorization of novel Alzheimer’s drug
The European Medicines Agency (EMA) has recommended the refusal of the marketing…
Grants for Bonn Researchers
Illuminating the brain: Dr. Sinead O’Sullivan, a neuroscientist at DZNE’s Bonn site, is receiving around 490,000 euros from the VolkswagenStiftung to investigate…
Curriculum vitae
Degrees 2009-2014 Ph.D. with summa cum laude in Immunology and Translational Medicine, Faculty of Medicine; University of Munich; Germany …
